Human induced pluripotent stem cell-derived cardiomyocytes for disease modeling and drug discovery.
Saved in:
| Title: | Human induced pluripotent stem cell-derived cardiomyocytes for disease modeling and drug discovery. |
|---|---|
| Authors: | Moriwaki T; Department of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ohta, Tokyo, Japan.; Kanagawa Institute of Industrial Science and Technology (KISTEC), Kawasaki, Kanagawa, Japan., Tani H; Department of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ohta, Tokyo, Japan., Tohyama S; Department of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ohta, Tokyo, Japan.; Kanagawa Institute of Industrial Science and Technology (KISTEC), Kawasaki, Kanagawa, Japan.; Keio University Regenerative Medicine Research Center, Kawasaki, Kanagawa, Japan. |
| Source: | Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2025 Oct 16; Vol. 13, pp. 1687840. Date of Electronic Publication: 2025 Oct 16 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101632513 Publication Model: eCollection Cited Medium: Print ISSN: 2296-4185 (Print) Linking ISSN: 22964185 NLM ISO Abbreviation: Front Bioeng Biotechnol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2296-4185 |
|---|---|
| DOI: | 10.3389/fbioe.2025.1687840 |
